CANAGLIFLOZIN, A SODIUM-GLUCOSE CO-TRANSPORTER 2 (SGLT-2) BLOCKER, NORMALIZES BLOOD GLUCOSE WITHOUT AFFECTING SYSTEMIC BLOOD PRESSURE, OXIDATIVE STRESS, INTRARENAL ANGIOTENSINOGEN GENE EXPRESSION AND KIDNEY INJURY IN TYPE 1 DIABETIC MICE

被引：0
|
作者：
Chan, John S. D. [1 ]
Chenier, Isabelle [1 ]
Ghosh, Anindya [1 ]
Wu, Chin-Han [1 ]
Lo, Chao-Sheng [1 ]
Zhao, Shuiling [1 ]
Chiasson, Jean-Louis [1 ]
Filep, Janos G. [2 ]
Ingelfinger, Julie R. [3 ]
Zhang, Shao-Ling [1 ]
机构：
[1] CHUM, Res Ctr, Montreal, PQ, Canada
[2] Hop Maison Neuve Rosemont, Res Ctr, Montreal, PQ H1T 2M4, Canada
[3] Massachusetts Gen Hosp, Pediat Nephrol Unit, Boston, MA 02114 USA
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2016年 / 31卷
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
SP374
引用
收藏
页码：214 / 214
页数：1
相关论文
共 50 条
  • [1] Sodium-glucose co-transporter (SGLT) and glucose transporter (GLUT) expression in the kidney of type 2 diabetic subjects
    Norton, Luke
    Shannon, Christopher E.
    Fourcaudot, Marcel
    Hu, Cheng
    Wang, Niansong
    Ren, Wei
    Song, Jun
    Abdul-Ghani, Muhammad
    DeFronzo, Ralph A.
    Ren, Jimmy
    Jia, Weiping
    DIABETES OBESITY & METABOLISM, 2017, 19 (09): : 1322 - 1326
  • [2] Mechanisms of blood pressure reduction with sodium-glucose co-transporter 2 (SGLT2) inhibitors
    Filippatos, T. D.
    Tsimihodimos, V.
    Elisaf, M. S.
    EXPERT OPINION ON PHARMACOTHERAPY, 2016, 17 (12) : 1581 - 1583
  • [3] Impacts of sodium-glucose co-transporter type 2 inhibitors on central blood pressure
    Takenaka, Tsuneo
    Ohno, Yoichi
    Suzuki, Hiromichi
    DIABETES & VASCULAR DISEASE RESEARCH, 2018, 15 (02): : 154 - 157
  • [4] Sodium-glucose co-transporter (SGLT)2 and SGLT1 renal expression in patients with type 2 diabetes
    Solini, Anna
    Rossi, Chiara
    Mazzanti, Chiara M.
    Proietti, Agnese
    Koepsell, Hermann
    Ferrannini, Ele
    DIABETES OBESITY & METABOLISM, 2017, 19 (09): : 1289 - 1294
  • [5] Blood Pressure Lowering and Sodium-Glucose Co-transporter 2 Inhibitors (SGLT2is): More Than Osmotic Diuresis
    Hillel Sternlicht
    George L. Bakris
    Current Hypertension Reports, 2019, 21
  • [6] Blood Pressure Lowering and Sodium-Glucose Co-transporter 2 Inhibitors (SGLT2is): More Than Osmotic Diuresis
    Sternlicht, Hillel
    Bakris, George L.
    CURRENT HYPERTENSION REPORTS, 2019, 21 (02)
  • [7] Two cases of atypical diabetic ketoacidosis (DKA) in patients with Type 2 diabetes on selective sodium-glucose co-transporter 2 (SGLT-2) inhibitors
    Shinton, C. A.
    Meeking, D.
    Lawrence, J. M.
    DIABETIC MEDICINE, 2016, 33 : 99 - 99
  • [8] Sodium-glucose co-transporter type 2 inhibitors reduce evening home blood pressure in type 2 diabetes with nephropathy
    Takenaka, Tsuneo
    Kishimoto, Miyako
    Ohta, Mari
    Tomonaga, Osamu
    Suzuki, Hiromichi
    DIABETES & VASCULAR DISEASE RESEARCH, 2017, 14 (03): : 258 - 261
  • [9] Sodium-Glucose Co-transporter 2 Inhibitors (SGLT2i); Shortterm Outcome in Diabetic Kidney Transplant Recipients
    Yagan, Jude
    Mahmoud, Tarek
    Hassan, Amal
    Geith, Osama
    El Serwey, Nabil
    Reda, Suzan
    Mustafa, Mohamed
    Shaker, Mohamed
    AlOtaibi, Torki
    TRANSPLANTATION, 2022, 106 (09) : S320 - S320
  • [10] Renoprotective mechanisms of sodium-glucose co-transporter 2 (SGLT2) inhibitors against the progression of diabetic kidney disease
    Ravindran, Sreenithya
    Munusamy, Shankar
    JOURNAL OF CELLULAR PHYSIOLOGY, 2022, 237 (02) : 1182 - 1205
12345